AIMM Insider Trading Activity and SEC Form 4 Filings
AIMM insider trading summary
No open-market insider purchases or sales of Autoimmune Inc (AIMM) have been reported on SEC Form 4 in the past 12 months.
Latest AIMM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 30, 2009 | Lusman Capital Management, LLC | 10% Owner | Buy | $2K (1,500 @ $1.40) |
| Jun 30, 2009 | Joel Lusman | 10% Owner | Buy | $2K (1,500 @ $1.40) |
| Jun 26, 2009 | Lusman Capital Management, LLC | 10% Owner | Buy | $94K (76,800 @ $1.22) |
| Jun 26, 2009 | Joel Lusman | 10% Owner | Buy | $94K (76,800 @ $1.22) |
| Feb 3, 2009 | Lusman Capital Management, LLC | 10% Owner | Buy | $1K (1,000 @ $1.08) |
| Feb 3, 2009 | Joel Lusman | 10% Owner | Buy | $1K (1,000 @ $1.08) |
| Feb 2, 2009 | Joel Lusman | 10% Owner | Buy | $7K (7,500 @ $0.93) |
| Feb 2, 2009 | Lusman Capital Management, LLC | 10% Owner | Buy | $7K (7,500 @ $0.93) |
| Jan 30, 2009 | Joel Lusman | 10% Owner | Buy | $98K (109,500 @ $0.89) |
| Jan 30, 2009 | Lusman Capital Management, LLC | 10% Owner | Buy | $98K (109,500 @ $0.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.